Gee we should have been focused 110% in getting RC220 into the clinic 12-18 months ago. I think this is one of the major issues over the past 18 months.
Hopefully it is delivered ahead of schedule before H2 2024.
Interesting Pete talking about deals by geography
China region 12.1m Anthracycline annual doses (16 times size of US). Mentioned Chinese companies can come in earlier on deals vs US big pharma.
Loved the question about recruitment for trials, think we are all a little burnt from Newcastle recruitment. $11m budget, throw another $5m in marketing but ensure this is recruited on time
Ann: Updated Strategy and Investor Presentation, page-141
-
- There are more pages in this discussion • 368 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |